SCHEMBL7947461

SCHEMBL7947461

N#Cc1ccc(COc2ccccc2N2CCN(c3ccncc3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HRH1 P35367 2/20 0.49
HRH3 Q9Y5N1 2/20 0.49
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
HTR6 P50406 3/20 0.43
SLC2A1 P11166 1/20 0.42
SLC2A3 P11169 1/20 0.42
MAOB P27338 1/20 0.42
TP53 P04637 1/20 0.42
MET P08581 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7947468 0.86 CYP19A1 (0.49) HTR1ASLC6A2SLC6A4SLC6A3HRH1
SCHEMBL7958198 0.84 CCR5 (0.52) HTR1ASLC6A2SLC6A4SLC6A3HRH1
SCHEMBL7947463 0.83 HRH3 (0.61) HRH1HRH3KDM4ESMN1; SMN2MAOB
SCHEMBL7954927 0.82 HRH1 (0.52) HTR1ASLC6A2SLC6A4SLC6A3HRH1
Hydrochloric Acid SCHEMBL2384578 0.75 HTR1A (0.77) HTR1ASLC6A2SLC6A4SLC6A3HTR6
SCHEMBL7956560 0.75 KDM4E (0.65) HRH1HRH3KDM4EPOLBSMN1; SMN2
SCHEMBL17827687 0.73 HRH1 (0.53) HTR1AHRH1HRH3KDM4EHTR6
SCHEMBL7958273 0.73 HRH1 (0.58) HRH1HRH3KDM4EPOLBSMN1; SMN2
SCHEMBL7958206 0.73 CCR5 (0.50) HTR1ASLC6A2SLC6A4SLC6A3HRH1
SCHEMBL8634780 0.73 SMN1; SMN2 (0.48) HRH1HRH3KDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed